Patents by Inventor John Charles Brennand

John Charles Brennand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods
    Publication number: 20040093627
    Abstract: The use of the G protein coupled receptor GPR56 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: May 13, 2004
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Methods
    Publication number: 20040093626
    Abstract: The use of the G protein coupled receptor GPR3 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: May 13, 2004
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Methods
    Publication number: 20040053812
    Abstract: The use of the G protein coupled receptor GPR22 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 18, 2004
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Methods
    Publication number: 20020082412
    Abstract: The use of the G protein coupled receptor GPR3 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: May 2, 2001
    Publication date: June 27, 2002
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Methods
    Publication number: 20020040132
    Abstract: The use of the G protein coupled receptor GPR56 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: May 2, 2001
    Publication date: April 4, 2002
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart